Noura S Abul-Husn, MD, PhD
- ASSOCIATE CLINICAL PROFESSOR | Medicine, Medical Genomics
Research Topics:Clinical Genomics, Genetics, Genomics
Noura S. Abul-Husn, MD, PhD is an Associate Professor of Medicine and Genetics, founding Chief of the Division of Genomic Medicine in the Department of Medicine, and Clinical Director of the Institute for Genomic Health at the Icahn School of Medicine at Mount Sinai. She is board certified in Internal Medicine and Medical Genetics.
Dr. Abul-Husn is a physician-scientist working to uncover the clinical impact of human genetic variation in diverse populations and drive the equitable implementation of genomic medicine. Her scientific contributions include pioneering genome-first approaches to provide novel clinical insights and inform therapeutic discovery. She is an expert at leveraging large-scale genomic data linked to electronic health records, and her work has been published in leading journals, including Science, Cell, and the New England Journal of Medicine. In her current role, Dr. Abul-Husn directs a genomic screening program for medically actionable conditions in the ancestrally diverse BioMe Biobank, and is leading efforts to integrate genomic risk information into clinical care for diverse patient populations. She participates in national consortium-based genomic medicine research, and is a principal investigator in the eMERGE (electronic Medical Records and Genomics) Network. Dr. Abul-Husn directs a new Genomic Health Clinic to provide the clinical infrastructure for genomic risk communication, and has initiated a Genomic Medicine Track for Internal Medicine residents to expand genomics knowledge across medical specialties.
Dr. Abul-Husn has a BSc Honors in Life Sciences and MSc in Pharmacology from Queen’s University in Canada. She completed her MD and PhD at the Icahn School of Medicine at Mount Sinai. She received the Terry Ann Krulwich Doctoral Dissertation Award for having the top thesis and was elected to the Alpha Omega Alpha Medical Honor Society. She completed residency in Internal Medicine and Medical Genetics at Mount Sinai, and was Chief Resident in Medical Genetics. Dr. Abul-Husn has senior-level pharmaceutical industry experience, having served as director of Translational Genetics at the Regeneron Genetics Center, during which time she was recognized by a 2017 Westchester’s 40 under 40 Rising Star Award.
- Genetic Counseling
Multi-Disciplinary Training AreasArtificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS]
MD, Icahn School of Medicine at Mount Sinai
PhD, Icahn School of Medicine at Mount Sinai
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Abul-Husn during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- 23andMe, Inc.
- 23andMe, Inc.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.